These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 37686889

  • 1. Outcome-Specific Efficacy of Different Probiotic Strains and Mixtures in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Xie P, Luo M, Deng X, Fan J, Xiong L.
    Nutrients; 2023 Sep 04; 15(17):. PubMed ID: 37686889
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Zhang T, Zhang C, Zhang J, Sun F, Duan L.
    Front Cell Infect Microbiol; 2022 Sep 04; 12():859967. PubMed ID: 35433498
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
    Sudha MR, Jayanthi N, Aasin M, Dhanashri RD, Anirudh T.
    Benef Microbes; 2018 Jun 15; 9(4):563-572. PubMed ID: 29695183
    [Abstract] [Full Text] [Related]

  • 4. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study.
    Majeed M, Nagabhushanam K, Natarajan S, Sivakumar A, Ali F, Pande A, Majeed S, Karri SK.
    Nutr J; 2016 Feb 27; 15():21. PubMed ID: 26922379
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
    Gupta AK, Maity C.
    Medicine (Baltimore); 2021 Jan 22; 100(3):e23641. PubMed ID: 33545934
    [Abstract] [Full Text] [Related]

  • 6. Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.
    Martoni CJ, Srivastava S, Leyer GJ.
    Nutrients; 2020 Jan 30; 12(2):. PubMed ID: 32019158
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T, Mozaffari S, Nikfar S, Abdollahi M.
    World J Gastroenterol; 2015 Mar 14; 21(10):3072-84. PubMed ID: 25780308
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
    Konstantis G, Efstathiou S, Pourzitaki C, Kitsikidou E, Germanidis G, Chourdakis M.
    Clin Nutr; 2023 May 14; 42(5):800-809. PubMed ID: 37031468
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
    Yuan F, Ni H, Asche CV, Kim M, Walayat S, Ren J.
    Curr Med Res Opin; 2017 Jul 14; 33(7):1191-1197. PubMed ID: 28166427
    [Abstract] [Full Text] [Related]

  • 10. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
    McFarland LV, Karakan T, Karatas A.
    EClinicalMedicine; 2021 Nov 14; 41():101154. PubMed ID: 34712929
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol.
    Yang M, Yu Y, Lei PG, Yuan J.
    BMJ Open; 2019 Dec 02; 9(12):e027376. PubMed ID: 31796470
    [Abstract] [Full Text] [Related]

  • 12. Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?
    Abhari K, Saadati S, Hosseini-Oskouiee F, Yari Z, Hosseini H, Sohrab G, Hejazi E, Agah S, Sadeghi A, Hekmatdoost A.
    Eur J Nutr; 2020 Aug 02; 59(5):2111-2117. PubMed ID: 31327047
    [Abstract] [Full Text] [Related]

  • 13. Different therapies of Chinese herbal medicine for diarrhea-predominant irritable bowel syndrome: A network meta-analysis of double-blinded, placebo-controlled trials.
    Liu N, Li J, Wang Y, Zhang S.
    J Ethnopharmacol; 2023 Dec 05; 317():116672. PubMed ID: 37328079
    [Abstract] [Full Text] [Related]

  • 14. Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.
    Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P.
    World J Gastroenterol; 2017 Jan 14; 23(2):336-344. PubMed ID: 28127207
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis.
    Goodoory VC, Khasawneh M, Black CJ, Quigley EMM, Moayyedi P, Ford AC.
    Gastroenterology; 2023 Nov 14; 165(5):1206-1218. PubMed ID: 37541528
    [Abstract] [Full Text] [Related]

  • 16. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis.
    Zhang Y, Li L, Guo C, Mu D, Feng B, Zuo X, Li Y.
    BMC Gastroenterol; 2016 Jun 13; 16(1):62. PubMed ID: 27296254
    [Abstract] [Full Text] [Related]

  • 17. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 13; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 18. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb 13; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 19. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs.
    Wang Y, Chen N, Niu F, Li Y, Guo K, Shang X, E F, Yang C, Yang K, Li X.
    Int J Colorectal Dis; 2022 Nov 13; 37(11):2263-2276. PubMed ID: 36251040
    [Abstract] [Full Text] [Related]

  • 20. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.
    Srivastava S, Basak U, Naghibi M, Vijayakumar V, Parihar R, Patel J, Jadon PS, Pandit A, Dargad RR, Khanna S, Kumar S, Day R.
    Gut Microbes; 2024 Nov 13; 16(1):2338322. PubMed ID: 38630015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.